Total investments received (USD): 23.75m
Round value (USD): 3.55m
Company: Exeliom Biosciences
Industry:
Biotech
Health services



Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain
United Kingdom